Shogo Endo

Dr. Shogo Endo

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
SYShuichi Yanai
Shuichi Yanai
SEShogo Endo
Shogo Endo
Aging is characterized generally by progressive and overall physiological decline of functions and is observed in all animals. A long line of evidence has established the laboratory mouse as the prime model of human aging. However, relatively little is known about the detailed behavioral and functional changes that occur across their lifespan, and how this maps onto the phenotype of human aging. To better understand age-related changes across the life-span, we characterized functional aging in male C57BL/6J mice of five different ages (3, 6, 12, 18, and 22 months of age) using a multi-domain behavioral test battery. Spatial memory and physical activities, including locomotor activity, gait velocity, and grip strength progressively declined with increasing age, although at different rates; anxiety-like behaviors increased with aging. Estimated age-related patterns showed that these functional alterations across ages are non-linear, and the patterns are unique for each behavioral trait. Physical function progressively declines, starting as early as 6 months of age in mice, while cognitive function begins to decline later, with considerable impairment present at 22 months of age. Importantly, functional aging of male C57BL/6J mouse starts at younger relative ages compared to when it starts in humans. Our study suggests that human-equivalent ages of mouse might be better determined on the basis of its functional capabilities.

1 July 2016 in Behavioural Brain Research
Verified
Journal Article
Closed access
SYShuichi Yanai
Shuichi Yanai
SEShogo Endo
Shogo Endo

1 April 2017 in Neuropharmacology
Verified
Journal Article
Closed access
SYShuichi Yanai
Shuichi Yanai
JTJun Toyohara
Jun Toyohara
KIKiichi Ishiwata
Kiichi Ishiwata
HIHideki Ito
Hideki Ito
SEShogo Endo
Shogo Endo

15 April 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
KTKumpei Tanisawa
Kumpei Tanisawa
EMEri Miyamoto Mikami
Eri Miyamoto Mikami
Noriyuki FukuNoriyuki Fuku
Noriyuki Fuku
YHYoko Honda
Yoko Honda
SHShuji Honda
Shuji Honda
Masashi TanakaMasashi Tanaka
Masashi Tanaka
Background: Senescence-accelerated mice (SAM) are a series of mouse strains originally derived from unexpected crosses between AKR/J and unknown mice, from which phenotypically distinct senescence-prone (SAMP) and -resistant (SAMR) inbred strains were subsequently established. Although SAMP strains have been widely used for aging research focusing on their short life spans and various age-related phenotypes, such as immune dysfunction, osteoporosis, and brain atrophy, the responsible gene mutations have not yet been fully elucidated.Results: To identify mutations specific to SAMP strains, we performed whole exome sequencing of 6 SAMP and 3 SAMR strains. This analysis revealed 32,019 to 38,925 single-nucleotide variants in the coding region of each SAM strain. We detectedOgg1p.R304W andMbd4p.D129N deleterious mutations in all 6 of the SAMP strains but not in the SAMR or AKR/J strains. Moreover, we extracted 31 SAMP-specific novel deleterious mutations. In all SAMP strains except SAMP8, we detected a p.R473W missense mutation in theLdb3gene, which has been associated with myofibrillar myopathy. In 3 SAMP strains (SAMP3, SAMP10, and SAMP11), we identified a p.R167C missense mutation in thePrxgene, in which mutations causing hereditary motor and sensory neuropathy (Dejerine-Sottas syndrome) have been identified. In SAMP6 we detected a p.S540fs frame-shift mutation in theIl4ragene, a mutation potentially causative of ulcerative colitis and osteoporosis.Conclusions: Our data indicate that different combinations of mutations in disease-causing genes may be responsible for the various phenotypes of SAMP strains.

30 September 2010 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
TSToshiro Sakamoto
Toshiro Sakamoto
SEShogo Endo
Shogo Endo

25 January 2014 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
SYShuichi Yanai
Shuichi Yanai
YSYuki Semba
Yuki Semba
HIHideki Ito
Hideki Ito
SEShogo Endo
Shogo Endo